Vivos (RDGL) Capital Leases (2010 - 2011)

Vivos (RDGL) posted Capital Leases of $711556.0 for Q3 2011, down 13.41% sequentially from $821792.0 in Q2 2011.

Vivos (RDGL) Capital Leases (2010 - 2011) Analysis & Trends

Vivos has reported Capital Leases for 2 years, with the latest figure at $711556.0 in Q3 2011.

Quarterly Capital Leases changed N/A year-over-year to $711556.0 in Q3 2011, while the trailing twelve-month figure through Sep 2011 was $711556.0 (changed N/A YoY) and the FY2010 annual result came in at $1.0 million, changed N/A from the prior year.
Capital Leases eased to $711556.0 in Q3 2011 per RDGL's latest filing, from $821792.0 in the prior quarter.
Over five years, Capital Leases peaked at $1.0 million in Q4 2010 and troughed at $711556.0 in Q3 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.49 Bn	193.88 Bn	7.27 Bn
2	Stryker	127.80 Bn	124.32 Bn	4.50 Bn
3	Medtronic	118.98 Bn	109.76 Bn	6.41 Bn
4	Boston Scientific	73.58 Bn	73.04 Bn	3.85 Bn
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn
6	Dexcom	34.34 Bn	32.39 Bn	830.00 Mn
7	GE HealthCare Technologies	33.76 Bn	31.66 Bn	2.18 Bn
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn
9	Steris	23.07 Bn	22.59 Bn	684.20 Mn
10	Vivos	24.90 Mn	23.34 Mn	-3,105.00

Download Data